小児感染症性胃腸炎におけるゼラチンタナート
Yvan Vandenplas1, Koen Huysentruyt1
1KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Translational gastroenterology and hepatology
|February 12, 2026
まとめ
ジェラチンタナートは,急性胃腸炎 (AGE) の小児における下痢期間を効果的に短縮します. この補助療法は,口服リヒダレーション溶液と併用され,24時間以内に迅速な有効性を示しています.
科学分野:
- 小児胃腸内科 小児胃腸内科
- 臨床薬理学 臨床薬理学とは
背景:
- 急性胃腸炎 (AGE) は,胃腸粘液と上皮損傷につながる.
- 経口再水分補給と共に補助療法を行うことは,小児性AGEにおける下痢の持続時間を短縮するために極めて重要です.
研究 の 目的:
- 小児のAGEの管理におけるゼラチンタナートの証拠をレビューし,議論する.
- ゼラチンタナートの効能と作用の開始を子どもで評価する.
主な方法:
- 複数のデータベース (MEDLINE,Embase,CINAHL,Cochrane,LILACS) のデータと灰色の文献のデータを体系的にレビューする.
- AGEの子どもを対象としたいくつかの臨床試験の分析,主にトルコ,イタリア,ルーマニア.
主要な成果:
- ゼラチンタナートは,下痢の持続期間を大幅に短縮し,12時間以内に便の一貫性を改善することを示しました.
- 一つの試験では,プラセボで2.0日,プラセボで3.75日 (P<0.001) を示した.
- ほとんどの試験は有益な結果を示したが,ポーランドの研究ではプラセボと比較して違いはなかった.
結論:
- ジェラチンタナートは,経口再水分溶液 (ORS) と併用すると,子供における伝染性AGEの管理に迅速かつ効果的です.
- 開発途上国におけるゼラチンタナートのさらなる調査は,現在の地理的分布の調査データのために正当化されています.
関連する概念動画
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
246
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
310
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
310
01:38What is the Immune System?
132.4K
Overview
132.4K